Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Banks

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Neuroscience and Biobehavioral Reviews|May 23, 2025
Mechanistic and translational insights from preclinical cocaine choice procedures on the economic substitutability of cocaine and nondrug reinforcersMadison M Marcus, Matthew L Banks
ASPET Discovery|April 24, 2026
Differential effects of acute versus repeated chemogenetic activation of the mesocorticolimbic dopamine pathway on cocaine choice in male and female TH:Cre ratsHannah L Robinson, Matthew L Banks
Frontiers in Behavioral Neuroscience|January 10, 2019
Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular MediatorsDeepika Mukhara, Matthew L Banks, Gretchen N Neigh
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2026
Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female ratsNicholas Heslep, Samuel A Marsh, Matthew L Banks
Behavioural Pharmacology|October 22, 2011
Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeysMatthew L Banks, Bruce E Blough, S Stevens Negus
Cold Spring Harbor Perspectives in Medicine|January 15, 2020
Medications Development for Treatment of Opioid Use DisorderE Andrew Townsend, S Stevens Negus, Matthew L Banks
The Journal of Pharmacology and Experimental Therapeutics|October 11, 2025
Fixed-proportion mixtures with the α2-adrenergic agonist clonidine or lofexidine do not alter fentanyl self-administration in non-opioid-dependent male and female ratsAllison Ortiz, Celsey M St Onge, Matthew L Banks
Trends in Pharmacological Sciences|October 23, 2018
Immunopharmacotherapies for Treating Opioid Use DisorderMatthew L Banks, Margaret E Olson, Kim D Janda
Journal of the Experimental Analysis of Behavior|January 6, 2022
Contextual extinction of drug-associated discriminative stimuli fails to attenuate drug-vs-food choice in rhesus monkeysMatthew L Banks, Blake A Hutsell, S Stevens Negus
Drug and Alcohol Dependence|January 8, 2022
Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in ratsMegan Jo Moerke, S Stevens Negus, Matthew L Banks
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Neuroscience and Biobehavioral Reviews|May 23, 2025
Mechanistic and translational insights from preclinical cocaine choice procedures on the economic substitutability of cocaine and nondrug reinforcersMadison M Marcus, Matthew L Banks
ASPET Discovery|April 24, 2026
Differential effects of acute versus repeated chemogenetic activation of the mesocorticolimbic dopamine pathway on cocaine choice in male and female TH:Cre ratsHannah L Robinson, Matthew L Banks
Frontiers in Behavioral Neuroscience|January 10, 2019
Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular MediatorsDeepika Mukhara, Matthew L Banks, Gretchen N Neigh
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2026
Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female ratsNicholas Heslep, Samuel A Marsh, Matthew L Banks
Behavioural Pharmacology|October 22, 2011
Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeysMatthew L Banks, Bruce E Blough, S Stevens Negus
Cold Spring Harbor Perspectives in Medicine|January 15, 2020
Medications Development for Treatment of Opioid Use DisorderE Andrew Townsend, S Stevens Negus, Matthew L Banks
The Journal of Pharmacology and Experimental Therapeutics|October 11, 2025
Fixed-proportion mixtures with the α2-adrenergic agonist clonidine or lofexidine do not alter fentanyl self-administration in non-opioid-dependent male and female ratsAllison Ortiz, Celsey M St Onge, Matthew L Banks
Trends in Pharmacological Sciences|October 23, 2018
Immunopharmacotherapies for Treating Opioid Use DisorderMatthew L Banks, Margaret E Olson, Kim D Janda
Journal of the Experimental Analysis of Behavior|January 6, 2022
Contextual extinction of drug-associated discriminative stimuli fails to attenuate drug-vs-food choice in rhesus monkeysMatthew L Banks, Blake A Hutsell, S Stevens Negus
Drug and Alcohol Dependence|January 8, 2022
Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in ratsMegan Jo Moerke, S Stevens Negus, Matthew L Banks
Pageof 15